Home
Products
Learn
About
Pricing
Log In
GTGN

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

πŸ‡¦πŸ‡Ί ASX

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

πŸ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

empty share chartempty share line

Performance graph isn't available yet for this share

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in GTGN

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in GTGN

N/A
GTGN investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in GTGN also invest in...

Want more shares? Try these...

Gratifii Limited

GTI

Gratifii Ltd. Is a technology company, which engages in the provision of customer engagement technology that delivers end-to-end technology solutions for businesses. The company is headquartered in Sydney, New South Wales. The company went IPO on 2008-07-17. The firm delivers end-to-end technology solutions for businesses to engage with their customers. The principal activities of the Company include the delivery of loyalty and rewards services to mid- to top-tier brands. The company offers mid-to-top tier brands. The firm offers loyalty solutions and reward content for businesses to engage with their customers. Its primary technology offering, Mosaic, is a configurable loyalty and rewards platform that businesses can implement to manage their loyalty programs. The firm also offers bespoke engagement programs, marketing services, and rewards content, such as entertainment, experiences, retail, theme parks and attractions, electronics, and gift cards. The company operates in Australia, New Zealand, Singapore, South Africa, and the United Arab Emirates. The company serves various sectors, including retail, hospitality, energy, technology, automotive, and financial services.

πŸ“Š Share price

$0.02 AUD
Find Out More

Genetic Technologies Ltd. is a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 52 full-time employees. The firm offers predictive genetic testing and risk assessment tools. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its GeneType and EasyDNA brands. The firm operates through three segments: EasyDNA, AffinityDNA, and geneType / Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. The geneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. GeneType also offers integrated risk testing for a range of serious conditions. EasyDNA and AffinityDNA offer deoxyribonucleic acid (DNA) testing services.

πŸ“Š Share price

$0.00 AUD